Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison
The DOI matches its Crossref record; 20 of the 23 references it cites were found in a registry or an index.
Abstract
The goals of this study were two-fold: (1) to test the hypothesis that retention of patients in naltrexone treatment could be improved by educating and preparing them for it while enrolled in a LAAM (l-alpha-acetylmethadol) detoxification program; and (2) to compare the safety and efficacy of 60 mg vs. 120 mg administered thrice weekly in a double-blind, sequential trial design. Patients were allowed a maximum of 365 days on naltrexone, and a maximum of four admissions; 119 patients received at least one dose of naltrexone. We found no clinically important differences between the two dosages, and retention in treatment was similar to that reported in earlier clinical trials. Slightly more than half the patients ever used heroin while receiving naltrexone, and only 9% of all urine tests were positive for opiates. Craving for heroin decreased dramatically by the end of the first week. We found no side-effect or toxicity due to naltrexone.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patient adherence and drop out has been a major stumbling block for oral naltrexone.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [115]
Citations
Cites
Flehinger, B. J. (1976) · Technometrics · doi:10.1080/00401706.1976.10489459 · Cited by 494
Conditioning factors in opiate addiction and relapse
Wikler, A. (1984) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(84)90008-4 · Cited by 279
Studies of EN-1639A (Naltrexone): A New Narcotic Antagonist
RESNICK, R. B., VOLAVKA, J., FREEDMAN, A. M., & THOMAS, M. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.6.646 · Cited by 197
An experimental study in the treatment of narcotic addicts with cyclazocine
Martin, W. R., Gorodetzky, C. W., & McClane, T. K. (1966) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196674455 · Cited by 127
Naloxone, naltrexone, and related noroxymorphones.
Blumberg, H., & Dayton, H. B. (1973) · PubMed · Cited by 108
Clinical Experience with Naltrexone
O'brien, C. P., Greenstein, R. A., Mintz, J., & Woody, G. E. (1975) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997509005662 · Cited by 82
D, A. G. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030061009 · Cited by 69
Psychopathology, Craving, and Mood during Heroin Acquisition: An Experimental Study
Mirin, S. M., Meyer, R. E., Mcnamee, H. B., & Mcdougle, M. (1976) · International Journal of the Addictions · doi:10.3109/10826087609056168 · Cited by 50
Craving in Heroin Addicts Maintained on the Opiate Antagonist Naltrexone
Sideroff, S. I., Charuvastra, V. C., Jarvik, M. E., & Ouren, J. (1978) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997809007017 · Cited by 43
Naltrexone treatment of opiate-dependent persons
Hollister, L. E., Schwin, R. L., & Kasper, P. (1977) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(77)90027-8 · Cited by 37
Cited by
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
Oral naltrexone maintenance treatment for opioid dependence
Minozzi, S., Amato, L., Vecchi, S., Davoli, M., Kirchmayer, U., & Verster, A. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001333.pub4 · Cited by 419
Gonzalez, J. P., & Brogden, R. N. (1988) · Drugs · doi:10.2165/00003495-198835030-00002 · Cited by 314
Naltrexone pharmacotherapy for opioid dependent federal probationers
Cornish, J. W., Metzger, D., Woody, G. E., Wilson, D., McLellan, A. T., Vandergrift, B., & O'Brien, C. P. (1997) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(97)00020-2 · Cited by 215
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans
Comer, S., Collins, E., Kleber, H., Nuwayser, E., Kerrigan, J., & Fischman, M. (2002) · Psychopharmacology · doi:10.1007/s002130100909 · Cited by 175
Metadata
- Authors
- Judson, B. A., Carney, T. M., & Goldstein, A.
- Affiliations
- Addiction Research Foundation (US)
- Venue
- Drug and Alcohol Dependence
- Publisher
- Elsevier BV
- Published
- 1981-07
- Volume
- 7
- Issue
- 4
- Pages
- 325-346
- ISSN
- 0376-8716 (ISSN-L)
- OpenAlex
- W2068113188
- Cited by
- 66
- References
- 23
- Citations by year
- 2018: 1 · 2016: 1 · 2013: 2 · 2012: 2
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Drug and Alcohol Dependence (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- naltrexone, heroin addiction, opioid use disorder, treatment retention, heroin craving, opioid withdrawal, drug safety, patient education
- MeSH terms
- Adolescent, Adult, Clinical Trials as Topic, Dose-Response Relationship, Drug, Double-Blind Method, Female, Heroin Dependence, Humans, Male, Middle Aged, Naloxone, Naltrexone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison. https://app.cochat.ai/papers/10.1016/0376-8716(81)90049-1
- The paper
- Judson, B. A., Carney, T. M., & Goldstein, A. (1981). Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison. Drug and Alcohol Dependence. https://doi.org/10.1016/0376-8716(81)90049-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.